« Back


Maternal Fetal Medicine

The research faculty in our department do incredible work in regards to research and how that research impacts healthcare around the world. Led by our Chairman, Dr. Gary Hankins, we continue to be at the forefront of innovative breakthroughs in healthcare and, despite drastic budget cuts in the past several years at the federal agency level, we continue to be at the top of the NIH funding lists for Obstetric and Gynecology departments around the country.

Cooperative Multicenter Maternal-Fetal Medicine Units Network (MFMU)

The major goal of this project is to participate with the NICHD under a cooperative agreement in an ongoing multicenter clinical program designed to investigate problems in clinical obstetrics, particularly those related to the prevention of low birth weight, prematurity, and medical problems of pregnancy. The most recently established of the Ob/Gyn Networks, the UTMB MFMU will contribute to the design and implementation of future Network studies as well as recruit, assess, and treat subjects in the ongoing clinical research of the Network. George R. Saade, MD, will incorporate his experience from the SCRN to successfully supervise the MFMU.

SaeedeGeorge Saade, MD PhD | Professor | Obstetrics and Gynecology

Our research focus is on how pregnancy affects long-term health for the mother and the child. I am also involved in multicenter clinical trials that test various interventions to improve pregnancy outcomes.


MAhmedMahmoud Ahmed, PhD | Professor | Obstetrics and Gynecology

The goal of our research program is to make more of the current medications available for treatment of the pregnant patient. This goal is achieved by two major projects namely, clinical and translational. The clinical is to determine the pharmacokinetics of the medication during pregnancy. The translational is to understand the role of human placenta in regulating fetal exposure to the medication throughout gestation. 

Sherif Abdel-RahmanSherif Abdel-Rahman, PhD | Associate Professor | Obstetrics and Gynecology

Our research program focuses on understanding the role of polymorphisms (inherited DNA sequence variations) in influencing individual sensitivity to environmental exposures and response to medications. The over arching goal is to improve our ability to estimate disease risk in human populations and to develop new personalized therapeutic modalities

ryttigErik Rytting, MD PhD | Associate Professor | Obstetrics and Gynecology

Our research seeks to improve therapeutic options when medication must be administered during pregnancy.  This includes understanding drug transfer across the placenta, pharmacokinetic studies to predict appropriate doses, and the development of nanomedicine for targeted drug delivery.

menonRamkumar Menon, PhD | Associate Professor | Obstetrics and Gynecology

Our research is focused on the mechanisms of pre-term premature rupture of the human fetal membrane (pPROM), which is associated with 40% of premature births and leading cause of neonatal morbidity and mortality. My laboratory is examining factors that cause premature aging (senescence) of human placenta as a cause of pPROM and prematurity.

vincentKathleen Vincent, MD | Clinical Assistant Professor | Obstetrics and Gynecology

Our research focuses on application of biomedical engineering technologies to women’s health research.  I utilize imaging from the cellular level to whole body imaging for the study of maternal-fetal health, obesity, benign gynecologic disorders, bacterial vaginosis, and vaginal drug delivery.  Additionally, I collaborate with women’s health researchers to bring novel technologies into their field of research.